Dr. Markus Peck-Radosavljevic discusses his manuscript "Low-dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in...
» More
Dr. Markus Peck-Radosavljevic discusses his manuscript "Low-dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease."